Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Low Dose Subcutaneous Interleukin-2 (IL-2) For The Treatment of Ulcerative Colitis.

NCT02200445 is registered in ClinicalTrials.gov with Scott B. Snapper, MD PHD as lead sponsor.

NCT NCT02200445
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02200445 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Low Dose Subcutaneous Interleukin-2 (IL-2) For The Treatment of Ulcerative Colitis.
Lead sponsor
Scott B. Snapper, MD PHD
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2015
Completion date
March 31, 2021
Enrollment
26 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis